HRSA to Host Webinar Tomorrow Ahead of 340B Hospital Recertification Window Opening Aug. 12

The annual 340B hospital recertification period will take place between Aug. 12 and Sept. 9.
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days After Legal Setback, Novartis Exempts Mississippi Providers From Contract Pharmacy Restrictions

Novartis exempted Mississippi 340B providers from its contract pharmacy restrictions following a new state law.
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

HRSA recently posted manufacturer notices to covered entities from SK Life Science, Dr. Reddy’s Laboratories, and Pfizer.
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Texas Hospitals Ask Judge to Block HHS’ DSH Calculation Rule That Impacts 340B Eligibility

A group of Texas hospitals urged a federal court to grant their request for a summary judgement—or at minimum preliminary relief—in a case challenging an HHS rule.
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware Legislature Passes Anti-Discrimination Protections for 340B Providers from PBMs but Drug Manufacturer Restrictions Remain

Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday.
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Adds Significant New Restrictions on 340B Contract Pharmacy Access; Alleges Lack of Oversight by HRSA, Pharmacies and TPAs

Lilly wordmark on top of building
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the company announced June 19 on the drug industry vendor site 340B ESP.
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Posts 340B Refund Notice for Insulin Product Humulin

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.
Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dual 340B Anti-Discrimination Bills, One Protecting Discounts in Contract Pharmacy Setting, Move Forward in Missouri

Missouri state capitol
Missouri lawmakers are making progress on two different 340B anti-discrimination bills.

With just weeks to go in its legislative session, Missouri lawmakers are making progress on two different 340B anti-discrimination bills.  Last week, a key Senate committee approved SB 26, comprehensive legislation with two key priorities:  prohibiting drug manufacturers from placing

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live